Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Investors to Reach Out
Keros Therapeutics(US:KROS) ACCESSWIRE Newsroomยท2025-01-17 15:00Core Viewpoint - Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into allegations against Keros Therapeutics, Inc. (KROS) and is encouraging investors to reach out for more information [1] Group 1 - The investigation is focused on potential misconduct or irregularities related to Keros Therapeutics, Inc. [1] - Investors are being urged to contact the firm for further details regarding the allegations [1]